Journal
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 123, Issue 5, Pages 662-675Publisher
OXFORD UNIV PRESS INC
DOI: 10.1309/GJWNPD8HU5MAJ837
Keywords
CD4; CD56; blastic NK cell
Categories
Funding
- NCI NIH HHS [R01CA90571] Funding Source: Medline
Ask authors/readers for more resources
Blastic natural killer (NK) cell lymphoma (also termed CD4+CD56+ hematodermic neoplasm) is a recently described entity, with the first case reported in 1994. It was suggested initially that the disease originates from NK cells. Since 1994, single cases and a few small series have been published. In this review, data from the literature and a series of 30 cases from the French and Dutch study groups on cutaneous lymphomas are discussed. The major clinical, histopathologic, and phenotypic aspects of the disease and diagnostic criteria and data suggesting a plasmacytoid dendritic cell origin for the tumor cells are provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available